Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) of a class action securities lawsuit.

The Asian Investor sees significant improvement in XPeng’s (XPEV) vehicle margin profile, leading to a more positive outlook on the stock. In contrast, Seeking Alpha analysts have made notable ...